Scimplify Takes $25 Million From Hitachi Ventures and Two Customers

Scimplify, a Bengaluru specialty-chemicals maker, announced a $25 million equity round on Oct. 14 led by Hitachi Ventures, with two of its own customers, Henkel and Teknor Apex, joining as new investors. The company declined to disclose a valuation.

TechCrunch reported the round after speaking with co-founder Sachin Santhosh, and Entrackr carried the same investor list. Accel India, Bertelsmann India Investments, Omnivore and 3one4 Capital, all existing backers, also took part. Scimplify's total equity funding now stands at $80 million, which by subtraction means $55 million was raised before this round.

What $25 million is set against

The figure that will travel is the valuation, and it is the one the company did not give. TechCrunch reported a $250 million post-money valuation that Scimplify declined to confirm, against $150 million at the $40 million Series B in March 2025. Neither valuation appears in the announcement coverage.

If the $250 million is right, it is 1.25 times the $200 million annualized revenue run rate Santhosh gave TechCrunch, a company-reported figure that has not been audited. A run rate extrapolates a recent period forward, so it says nothing about the trailing twelve months. Santhosh also said Scimplify has been EBITDA-positive for two months and expects to turn profitable after tax in October.

1. U.S. run rate a year ago10 $ million
2. U.S. run rate now60 $ million
3. Total run rate now200 $ million
4. Total target within a year400 $ million

Source: TechCrunch, Oct. 14, 2026, citing co-founder Sachin Santhosh

Customers as shareholders

Henkel and Teknor Apex both buy from Scimplify, which makes them buyers and owners at once. Entrackr said Teknor Apex will also serve as a manufacturing partner for the U.S. expansion. Neither article says whether the investments carry purchase commitments, and that is the term that would show whether the money is financing or a supply contract.

The same shape appeared on Vesta's $30 million Series B, where three lenders already using the software supplied the money. Stryker's $400 million into CMR Surgical is the larger version, with a buyout option attached. Scimplify has disclosed no such option.

Where the money goes

Item	Amount or detail	Source
U.S. expansion, including manufacturing	About $7.5 million, allocation may change	TechCrunch
Scinode, the AI platform	About $2 million	TechCrunch
Production footprint	More than 500 facilities, about 90% in India	TechCrunch
Planned new production	U.S. and Japan within a year	TechCrunch

Those two disclosed lines add up to $9.5 million, or 38 percent of the round. The remaining $15.5 million has no itemised purpose in either article, beyond Entrackr's list of U.S. research, processing and feedstock for critical metals and rare earths.

The business model is also easy to misread. Scimplify does not own plants at scale: it routes orders through a network of more than 500 manufacturing facilities and uses Scinode, which Entrackr says maps those facilities, to match them to a customer's specification. TechCrunch quoted Santhosh as saying some jobs went from requirements to finished material in two months, against 12 to 18 months typically. That is the company's own comparison.

About 90 percent of production still happens in India. Customers outside India supply more than half of revenue, up from under 5 percent about 18 months earlier, and the U.S. alone is about 30 percent. Energy, electronics and defense materials make up 45 to 50 percent of revenue, up from under 15 percent a year earlier, according to TechCrunch.

The next observable test is the U.S. build-out Santhosh described for the coming year. A named plant, site or partner agreement would show whether the $7.5 million buys production or only an office.